Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds

被引:109
|
作者
Baer-Dubowska, W [1 ]
Szaefer, H [1 ]
Krajka-Kuzniak, V [1 ]
机构
[1] K Marcinkowski Univ Med Sci, Dept Pharmaceut Biochem, PL-60780 Poznan, Poland
关键词
D O I
10.1080/004982598239155
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effect of the phenolic compounds protocatechuic acid, chlorogenic acid, tannic acid, gallates and silybin on ethoxyresorufin O-dealkylase (CYP1A1), methoxyresorufin O-dealkylase (CYP1A2) and pentoxy-O-dealkylase (CYP2B) was examined in mouse liver microsomes from induced animals. 2. All compounds tested could inhibit cytochrome P450-mediated enzyme activities, but to different extents. Tannic acid was the most potent inhibitor, especially toward EROD activity with an IC50 = 2.6 mu M. Synthetic dodecyl gallate was also relatively selective toward this enzyme activity with an IC50 = 120 mu M. 3. Protocatechuic acid, chlorogenic and silybin were more selective towards PROD and MROD activities. Their relative inhibitory potency for PROD activity was as follows: chlorogenic acid > protocatechuic acid > silybin > dodecyl gallate > propyl gallate. Protocatechuic acid was a more effective inhibitor of MROD activity than chlorogenic acid, and propyl gallate more effective than dodecyl gallate. Thus, no clear structure-activity or selectivity relationship was observed. 4. Analysis of the kinetics of inhibition revealed that the inhibition in most cases was non-competitive in nature.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 50 条
  • [1] Inhibition of human hepatic microsomal cytochrome P450 activities by herbal extracts of kava
    Mathews, J
    Etheridge, A
    Black, S
    DRUG METABOLISM REVIEWS, 2002, 34 : 175 - 175
  • [2] HEPATIC-MICROSOMAL CYTOCHROME P450 SYSTEM IN MURINE HEPATIC SCHISTOSOMIASIS
    ELMOUELHI, M
    BLACK, M
    PHILLIPS, SM
    DOUGHTY, B
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1175 - 1175
  • [3] Molecular requirements for inhibition of cytochrome P450 activities by roquefortine
    Aninat, C
    Hayashi, Y
    André, F
    Delaforge, M
    CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (09) : 1259 - 1265
  • [4] Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase
    Henderson, CJ
    Otto, DME
    Carrie, D
    Magnuson, MA
    McLaren, AW
    Rosewell, I
    Wolf, CR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) : 13480 - 13486
  • [5] In vitro inhibition of hepatic cytochrome P450 and enzyme activity by butyltin compounds in marine mammals
    Kim, GB
    Nakata, H
    Tanabe, S
    ENVIRONMENTAL POLLUTION, 1998, 99 (02) : 255 - 261
  • [6] Effects of several organophosphates on hepatic cytochrome P450 activities in rats
    Abdou, Rania H.
    Elbadawy, Mohamed
    Khalil, Waleed F.
    Usui, Tatsuya
    Sasaki, Kazuaki
    Shimoda, Minoru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (05): : 598 - 606
  • [7] Effects of Several Pyrethroids on Hepatic Cytochrome P450 Activities in Rats
    Abdou, Rania
    Sasaki, Kazuaki
    Khalil, Waleed
    Shah, Syed
    Murasawa, Youhei
    Shimoda, Minoru
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2010, 72 (04): : 425 - 433
  • [8] Effects of propofol on human hepatic microsomal cytochrome P450 activities
    McKillop, D
    Wild, MJ
    Butters, CJ
    Simcock, C
    XENOBIOTICA, 1998, 28 (09) : 845 - 853
  • [9] Inhibition of cytochrome P450 by buckminsterfullerene
    Gannett, Peter
    Bostick, Christopher
    Tracy, Timothy
    Dolan, Emma
    Biundo, Andrew
    Tish, Wesley
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [10] Inhibition of cytochrome P450 by thiarubrine A
    Fowler, JL
    Quinones, K
    O'Shea, KE
    Roberts-Kirchhoff, ES
    DRUG METABOLISM REVIEWS, 2004, 36 : 148 - 148